Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M456Revenue $M60.6Net Margin (%)-122.0Z-Score-4.1
Enterprise Value $M367EPS $-0.9Operating Margin %-117.3F-Score5
P/E(ttm))0Cash Flow Per Share $-1.8Pre-tax Margin (%)-122.0Higher ROA y-yY
Price/Book8.410-y EBITDA Growth Rate %0Quick Ratio3.5Cash flow > EarningsY
Price/Sales8.35-y EBITDA Growth Rate %0Current Ratio3.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-47.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)-94.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M71.4ROI % (ttm)-64.4Gross Margin Increase y-yY

Gurus Latest Trades with PACB

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PACBLee Ainslie 2013-09-30 Add0.17%$2.5 - $5.98
($3.45)
$ 6.3985%Add 64.63%5,814,719
PACBJean-Marie Eveillard 2012-09-30 Sold Out -0.0013%$1.7 - $2.32
($1.97)
$ 6.39224%Sold Out0
PACBJohn Griffin 2012-06-30 Sold Out -0.05%$1.83 - $3.7
($2.48)
$ 6.39158%Sold Out0
PACBJean-Marie Eveillard 2012-03-31 Buy $2.94 - $5.04
($3.71)
$ 6.3972%New holding, 150000 sh.150,000
PACBGeorge Soros 2011-09-30 Sold Out -0.0018%$3.55 - $12.24
($7.91)
$ 6.39-19%Sold Out0
PACBGeorge Soros 2011-06-30 Buy $10.44 - $13.53
($11.8)
$ 6.39-46%New holding, 10700 sh.10,700
PACBJohn Griffin 2011-03-31 Buy 0.21%$12.94 - $16.3
($15)
$ 6.39-57%New holding, 870000 sh.870,000
PACBLee Ainslie 2010-12-31 Buy 0.54%$11.53 - $16.97
($13.88)
$ 6.39-54%New holding, 3543333 sh.3,543,333
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PACB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PACB Lee Ainslie 2014-12-316,459,7849.050.79
Premium Most recent portfolio changes are included for Premium Members only!


PACB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dow Brian BVP and PAO 2015-03-02Buy2,503$4.9130.14view
CORCORAN KEVIN PSVP, Market Development 2015-03-02Buy2,816$4.9130.14view
Phillips James MichaelSVP, Research & Development 2015-03-02Buy1,877$4.9130.14view
Ericson William W.Director 2014-08-19Buy39,299$5.1424.32view
Ericson William W.Director 2014-08-18Buy135,155$5.0925.54view
Ericson William W.Director 2014-08-14Buy77,822$527.8view
Ericson William W.Director 2014-08-13Buy29,435$4.9329.61view
Ericson William W.Director 2014-08-12Buy123,423$4.8930.67view
Ericson William W.Director 2014-08-11Buy143,300$4.8731.21view
Ericson William W.Director 2014-08-08Buy51,423$4.930.41view

Press Releases about PACB :

    Quarterly/Annual Reports about PACB:

    News about PACB:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: CLR, CLMS, OPK, PACB, GAIN Dec 16 2013 
    Weekly CEO Buys Highlight: OPK, PACB, CUBI, ARCP, RLYP Nov 25 2013 
    Weekly CEO Buys Highlight: PHII, TUES, PACB, IPHI, WMC Dec 09 2012 
    Weekly CEO Buys Highlight: PACB, AKS, EPIQ, GGS, TPGI Dec 02 2012 
    Weekly CEO Buys Highlight: FFIN, STEC, MPO, PACB, TPGI Nov 25 2012 
    Weekly CEO Buys Highlight: SUNS, PACB, GM, NPO, DGX Aug 11 2012 

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Mar 05 2015
    DNAnexus Enables Seamless Assembly of PacBio Data for J. Craig Venter Genome Mar 02 2015
    Pacific Biosciences Enables Reference-Quality De Novo Human Genome Assemblies Mar 02 2015
    Pacific Biosciences Enables Reference-Quality De Novo Human Genome Assemblies Mar 02 2015
    10X Genomics Unwraps Its 'Toaster Oven' For Better DNA Sequencing Feb 25 2015
    Five Things To Watch For At The Big Genomics Event Feb 24 2015
    What 23andMe's FDA Approval Means For The Future Of Genomics Feb 20 2015
    Pacific Biosciences Reports Fourth Quarter 2014 Financial Results Feb 11 2015
    Pacific Biosciences Posts Q4 Loss as Expected, Shares Fall - Analyst Blog Feb 04 2015
    Pacific Biosciences reports 4Q loss Feb 03 2015
    Pacific Biosciences reports 4Q loss Feb 03 2015
    Pacific Biosciences of California Inc Earnings Call scheduled for 4:30 pm ET today Feb 03 2015
    Pacific Biosciences Reports Fourth Quarter 2014 Financial Results Feb 03 2015
    Q4 2014 Pacific Biosciences of California Inc Earnings Release - After Market Close Feb 03 2015
    Will Pacific Biosciences (PACB) Surprise on Earnings in Q4? - Analyst Blog Feb 02 2015
    Pacific Biosciences of California, Inc. Fourth Quarter and Year End 2014 Financial Results Call Jan 12 2015
    Stealthy 10X Genomics Raises $55.5M To Beef Up DNA Sequencing Jan 12 2015
    Pacific Biosciences of California, Inc. Fourth Quarter and Year End 2014 Financial Results Call Jan 09 2015
    Pacific Biosciences Customers Present Work on Complex De Novo Genomes and Genome Annotation at the... Jan 05 2015
    Pacific Biosciences Appoints Kathy Ordonez to Board of Directors Dec 18 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK